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Secretory factors from OP9 stromal 
cells delay differentiation and 
increase the expansion potential of 
adult erythroid cells in vitro
Kongtana Trakarnsanga1,2, Marieangela C. Wilson2, Kate J. Heesom2, Tatyana N. Andrienko2, 
Chatchawan Srisawat1 & Jan Frayne2
Development of in vitro culture systems for the generation of red blood cells is a goal of scientists 
globally with the aim of producing clinical grade products for transfusion. Although mature 
reticulocytes can be efficiently generated by such systems, the numbers produced fall short of that 
required for therapeutics, due to limited proliferative capacity of the erythroblasts. To overcome this 
hurdle, approaches are required to increase the expansion potential of such culture systems. The OP9 
mouse stromal cell line is known to promote haematopoietic differentiation of pluripotent stem cells, 
however an effect of OP9 cells on erythropoiesis has not been explored. In this study, we show not only 
OP9 co-culture, but factors secreted by OP9 cells in isolation increase the proliferative potential of adult 
erythroid cells by delaying differentiation and hence maintaining self-renewing cells for an extended 
duration. The number of reticulocytes obtained was increased by approximately 3.5-fold, bringing it 
closer to that required for a therapeutic product. To identify the factors responsible, we analysed the 
OP9 cell secretome using comparative proteomics, identifying 18 candidate proteins. These data reveal 
the potential to increase erythroid cell numbers from in vitro culture systems without the need for 
genetic manipulation or co-culture.
Development of in vitro culture systems for the generation of red blood cells has become a goal for scientists 
globally with the aim of producing clinical grade blood products for transfusion. Erythroid cells can be efficiently 
differentiated to reticulocytes from adult peripheral blood stem cells, however, extrapolated cell numbers fall 
short of the level required for therapeutics, due to limited proliferation capacity1. Strategies are therefore required 
to overcome this hurdle.
Macrophages are believed to facilitate erythroblast proliferation in vivo, with both adhesion molecules and 
secreted factors implicated (reviewed by Klei et al.2). Macrophages have also been shown to stimulate erythroid 
cell expansion in vitro, although direct contact with erythroid cells is required3. Addition of a cytoprotective pol-
ymer (poloxamer 188) to the culture medium of late stage erythroid cells has been shown to enhance survival of 
the cells and increase overall yield by 1.5 fold4. Other approaches, such as inhibition of FOXM15 have also been 
shown to have, albeit a small positive effect on erythroid cell numbers. Hence identification of additional novel 
factors to increase expansion of erythroid cell numbers in vitro is required. Furthermore, as different factors may 
act on different pathways, combinatorial approaches utilising synergistic effects may enable greater expansion 
rates to be achieved.
The OP9 stromal cell line was established from a mouse with a M-CSF (macrophage colony stimulating fac-
tor) gene mutation resulting in lack of M-CSF production from this cell line6. Stromal cells producing M-CSF 
induce the differentiation of embryonic stem cells (ESC) down the monocyte-macrophage linage6. In contrast 
OP9 stromal cells lacking M-CSF promote differentiation down other haematopoietic linages (erythroid, myeloid 
and B- cell)6–11. Likewise, OP9 cells have been used in co-culture to support erythroid differentiation of pluripo-
tent stem cells and to improve terminal differentiation12,13. In contrast adult peripheral blood stem cells undergo 
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efficient erythroid differentiation in vitro without the need for support cells14. However, an effect of OP9 cells on 
the proliferation of adult erythroid cells has not previously been explored.
In this study we show that factors secreted by OP9 cells increase the proliferative capacity and hence yield of 
adult erythroid cultures, by delaying differentiation and hence maintaining self-renewing cells for an extended 
duration.
Results
Co-culture with OP9 cells increases proliferation potential of adult erythroid cell culture by 
delaying differentiation. To study the effect of OP9 cells on the proliferation potential of erythroblasts 
the cells were initially incubated under co-culture conditions. Adult peripheral blood CD34+ haematopoietic 
progenitors were isolated from leukocyte-reduction system cones obtained from healthy donors. Aliquots of 104 
CD34+ cells were seeded on a layer of confluent OP9 cells, or incubated without OP9 cells (control culture). The 
cells were cultured using the 3-stage erythroid culture system described by Griffith et al.14, with additional fetal 
bovine serum (10% rather than 2% v/v) to support the OP9 cells (no difference was observed between expansion 
or differentiation of erythroid cells cultured in 2% or 10% fetal bovine serum; data not shown). Cells were sequen-
tially transferred between the primary, secondary and tertiary media of the culture system for an overall culture 
duration of 22 days. Cell number and viability was assessed throughout the culture. A sample of cells was also 
collected on day 20 of culture for morphological analysis.
Initially, during the first 11 days of culture, there appeared to be fewer cells in the OP9 co-culture compared 
to the control culture. However, visualization by phase contrast microscopy showed a substantial proportion of 
erythroblasts attached to the OP9 cells (Fig. 1a) which were excluded from the cell count, only detached cells 
being counted; the total cell number obtained is therefore an underestimate. Notwithstanding, from day 11 of 
culture a clear distinction between the cultures was apparent, with expansion rate of the control culture showing 
a marked decline (average 1.1-fold increase to day 18) whereas cell numbers in the OP9 co-culture continuing 
to double (Fig. 1b). Overall expansion of cell numbers in the OP9 co-culture was significantly higher than in the 
control culture, ~1.5 × 104 compared to ~6 × 103 respectively (n = 3; p < 0.001). There were still erythroblasts 
attached to the OP9 cells at the end of the culture, although substantially fewer than at early time points (Fig. 1a). 
Analysis of erythroid cell morphology on day 20 showed a significantly greater proportion of orthochromatic 
erythroblasts in the OP9 (57.2% ± 1.6%) compared to the control culture (8.6% ± 1.7%; n = 3, p < 0.001), along 
with 7.1% ± 1.7% polychromatic erythroblasts, whereas most cells in the control culture had already enucle-
ated (Fig. 1c, Suppl Table 1), indicating delayed differentiation of a proportion of cells in the OP9 co-culture. 
To obtain morphological analysis at earlier time points the cultures were repeated. At day 14 almost 50% more 
pro-erythroblasts were detected in the OP9 compared to control culture. At day 18 a population of basophilic 
erythroblasts (8.6% ± 2.8%) was still present in the OP9 co-culture along with 19.3% ± 2.6% polychromatic eryth-
roblasts, whereas all cells in the control culture had differentiated to orthochromatic erythroblasts or reticulocytes 
(Suppl Fig. 1; Table 1). Hence, the increased number of cells obtained in the OP9 co-cultures is due to persistence 
of earlier erythroblasts with proliferative potential to later stages of the culture compared to the control cultures.
There was no obvious correlation between detachment of erythroblasts from the OP9 cells and erythroid mat-
uration, cells at all stages of differentiation detected in the detached fraction (Suppl Fig. 1). A small proportion 
of OP9 cells differentiated to adipocyte-like cells as has been observed previously15, however the number did not 
increase notably during the cultures (Fig. 1a).
Direct contact of erythroblasts with OP9 cells is not required to delay differentiation of eryth-
roid cells. To determine whether direct contact of erythroblasts with OP9 cells is required, OP9 cells were 
seeded and maintained in wells of a tissue culture plate until confluent. Aliquots of 2,500 CD34+ progenitors were 
either seeded directly onto the OP9 cells or onto a NUNC tissue culture insert within the well of a tissue culture 
plate, preventing direct contact between the OP9 and CD34+ cells. The co-cultures were performed using the 
3-stage erythroid culture system as for the previous experiment. The expansion profile for erythroblasts in direct 
contact with OP9 cells was the same as in experiment 1 above. However, unlike the control culture, in which the 
expansion rate declined from day 11, the number of erythroid cells in cultures with indirect exposure to OP9 cells 
continued to increase, paralleling the profile of the cultures with direct contact (Fig. 2a). There was no difference 
in the number of cells from this time point onwards between the two groups, or in the overall expansion of cell 
numbers. The morphology of cells on day 20 was also similar between the groups (Fig. 2b; Suppl Table 2). Hence 
direct contact between the OP9 cells and erythroblasts is not required to delay differentiation of erythroblasts.
Conditioned medium from OP9 cells delays differentiation and facilitates prolonged expan-
sion of erythroblasts. The use of co-culture, particularly inclusion of cells of non-human origin, is both 
in-practical and undesirable when considering therapeutic development. Our next step was therefore to deter-
mine if conditioned media from OP9 cells was adequate to obtain the observed effects. OP9 cells were incubated 
in primary, secondary and tertiary media for 48 hours, the media collected and filtered to remove any contam-
inating cells. Aliquots of 104 CD34+ cells were incubated in these media or in the normal 3-stage media. Cells 
were counted throughout the culture. The number of erythroid cells in cultures with OP9-conditioned media was 
significantly higher at all time points from day 9 onwards than in control cultures (Fig. 3a). Overall expansion 
of cell numbers in the OP9-conditioned media was also significantly higher than in the control media, ~7 × 104 
compared to ~2 × 104 respectively (n = 3; p < 0.001). Since this experiment was performed using only liquid 
culture conditions the number of cells could be maintained at optimal concentrations for each stage14 which 
results in higher numbers of cells in the control group than in previous experiments. On day 16, cultures with 
OP9-conditioned media had significantly more polychromatic erythroblasts still present (6.6% ± 1.2%) than con-
trol cultures (1.6% ± 0.2%; n = 3, p < 0.001) (Fig. 3b,c). Coupled with the greater overall number of cells obtained 
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Figure 1. OP9 co-culture delays differentiation of erythroid cells. CD34+ cells were cultured with and without 
OP9 stromal cells in an erythroid differentiation culture. (a) Erythroblasts (red arrows) attached to OP9 stromal 
cells (blue arrows) at day 7 and day 26 of the co-culture taken under phase contrast microscopy (scale bars 100 
μm). Yellow arrows indicate adipocytes. (b) Comparison of the number of erythroid cells from day 0 to day 
22 in control liquid and OP9 co-culture (for OP9 co-culture, only detached cells being counted) (mean ± SD; 
n = 3, *p < 0.05, **p < 0.0; student’s t test). (c) Erythroid cells from OP9 co-culture and liquid culture at 
day 20 stained with Leishman reagent and analyzed by light microscopy (scale bars 10 μm). Orange arrows 
indicate polychromatic erythroblasts, black arrows indicate orthochromatic erythroblast, red arrows indicate 
reticulocytes.
Pro Baso Poly Ortho Retics
Liquid d8 70.8% ± 2.3% 27% ± 1.1% 2.2% ± 1.3% 0% 0%
OP9 d8 74.8% ± 2.5% 23.4% ± 1.5% 1.8% ± 1.0% 0% 0%
Liquid d14 8.6% ± 1.4% 11.7% ± 1.3% 23.5% ± 2.0% 33.4% ± 3.1% 22.8% ± 1.0%
OP9 d14 14.1% ± 1.6% 12.2% ± 2.9% 27.2% ± 1.9% 31.5% ± 2.9% 15.0% ± 0.6%
Liquid d18 0% 0% 0% 24.3% ± 4.4% 75.7% ± 4.4%
OP9 d18 0% 8.6% ± 2.8% 19.3% ± 2.6% 32.9% ± 1.8% 39.2% ± 4.4%
Table 1. Morphological analysis of erythroid cells at different time points in the cultures with and without OP9 
cells (mean ± SD, n = 3).
www.nature.com/scientificreports/
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with OP9-conditioned media, the data indicate factors secreted by the OP9 cells delay differentiation and facilitate 
prolonged expansion of earlier erythroid cell populations. At later time points, the cultures were more synchro-
nous than in the previous experiments, with similar proportions of orthochromatic erythroblasts and reticulo-
cytes (Table 2), however the total number of these cell types were significantly higher in the OP9-conditioned 
media; at day 19, 5.57 × 107 ± 8 × 106 orthochromatics* and 5.4 × 108 ± 2.7 × 107 reticulocytes** compared to 
1.66 × 107 ± 3.63 × 106 orthochromatics and 1.57 × 108 ± 2.98 × 107 reticulocytes respectively in the control 
media (n = 3, *p = 0.0015, **p < 0.001).
Identification of OP9 secretory proteins using isobaric Tandem Mass Tag labelling and mass 
spectrometry. Finally, to identify factors in the OP9-conditioned media that may act on the erythroblasts 
to delay differentiation, isobaric Tandem Mass Tag labelling and nanoLC-MS/MS was used11 to compare the 
abundance of proteins in the OP9-conditioned and normal (control) media (see Methods). The raw data files 
were processed and quantified using Proteome Discoverer software v2.1 (Thermo Scientific) and searched against 
the UniProt Mouse (78740 entries) database using the SEQUEST algorithm to identify proteins secreted by the 
murine OP9 cells. For analysis only quantifications obtained from two or more unique peptides per protein 
were considered, with a comparative threshold of 216. Using these criteria, 90 proteins were quantified (Suppl 
Table 3A). As cells with self-renewal capacity were detected in all 3 media of the culture system, we screened the 
data for proteins that were consistently at a higher level across all three OP9-conditioned media compared to 
respective control media, identifying 18 proteins (Table 3). No proteins were at a higher level across the control 
media. However, to confirm that the proteins identified at a higher level in the OP9-conditioned media originated 
Figure 2. Direct contact of erythroblasts with OP9 cells is not required to delay differentiation of erythroid 
cells. CD34+ cells were maintained in OP9 co-culture with or without direct contact between the erythroid 
and OP9 cells (a) Comparison of the number of erythroid cells from day 0 to day 22 in OP9 co-culture with 
or without direct contact between the erythroid and OP9 cells (mean ± SD; n = 3, p > 0.05 at all time points; 
student’s t test). (b) Erythroid cells from OP9 co-culture with and without direct contact at day 20 stained with 
Leishman reagent and analyzed by light microscopy (scale bars 10 μm). Orange arrows indicate polychromatic 
erythroblasts, black arrows indicate orthochromatic erythroblast, red arrows indicate reticulocytes.
OP9 conditioned media control media p value
Orthochromatic 9.3% ± 1.1% 9.6% ± 1.7% 0.825976502
Reticulocyte 90.7% ± 1.1% 90.4% ± 1.7% 0.825976502
Table 2. Morphological analysis of day 19 erythroid cells maintained in OP9 conditioned media and control 
media (mean ± SD, n = 3, student’s t-test).
www.nature.com/scientificreports/
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from the OP9 cells, and not from the serum components of the media with variation in level introduced during 
preparation, we next searched the raw data files against the UniProt Human (134169 entries) and Bovine (31855 
entries) databases (Suppl Tables 3B and C). Again, no proteins were consistently detected at a higher level across 
the control media. However, 7 proteins at a higher level across all OP9 media were detected on screening the 
bovine database and 8 on screening the human database, 11 of which were common to those identified at a 
higher level across OP9 media from the mouse database search. We therefore interrogated the data for each indi-
vidual peptide to identify the source of the proteins. Peptides with sequences specific to just the bovine and/or 
Figure 3. OP9-conditioned culture media delays differentiation of erythroid cells and increases expansion 
potential of cultures. CD34+ cells were cultured with OP9-conditioned culture media or control culture media 
for 19 days. (a) Comparison of the number of erythroid cells from day 0 to day 19 in cultures with OP9-
conditioned media or control media (mean ± SD; n = 3, *p < 0.05, **p < 0.01; student’s t test). (b) Erythroid 
cells maintained in OP9-conditioned culture media or control culture media at day 16 and 19 stained with 
Leishman reagent and analyzed by light microscopy (scale bars 10 μm). Orange arrows indicate polychromatic 
erythroblasts, black arrows indicate orthochromatic erythroblast, red arrows indicate reticulocytes. (c) 
Morphological analysis of day 16 erythroid cells maintained in OP9 conditioned media and control media 
(mean ± SD; n = 3, *p < 0.05, **p < 0.01; student’s t test).
www.nature.com/scientificreports/
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human orthologue of a protein, were not at a higher level across the OP9 conditioned media, only peptides with a 
sequence also common to the mouse being higher. In contrast 15 of the proteins detected at a higher level across 
all OP9 conditioned media from the mouse database search had mouse specific peptides which were at a higher 
level (Suppl Table 4). For the remaining 3 proteins all peptides detected were common to the mouse and bovine 
and/or human orthologues. Thus, the proteins detected at a higher level from the bovine and human database 
searches were quantified only from peptides common to the respective mouse orthologue. The analyses confirm 
that all 18 candidate proteins identified were secreted by the OP9 cells and not of human or bovine origin.
Discussion
This study shows that co-culture of adult peripheral blood CD34+ haematopoietic stem cells with OP9 stromal 
cells maintains a population of self-renewing erythroblasts for a prolonged period, resulting in an increased cell 
yield per culture. Moreover, direct contact between OP9 cells and erythroblasts is not required, the same effect 
being achieved even with OP9 conditioned media; the number of reticulocytes obtained consistently around 3.5 
fold higher than in control cultures.
Previous studies have utilized co-culture with macrophages to enhance in vitro erythropoiesis, based on the 
premise that in vivo erythropoiesis occurs in erythroblastic islands supported by a central macrophage. Such mac-
rophages are surrounded by various stages of developing erythroid cells, from CFU-E to reticulocytes17, and are 
believed to be important for supporting erythroblast proliferation and differentiation17. However, macrophages 
are clearly not essential in vitro as erythroid cells can be successfully differentiated from CD34+ cells in isolation 
with high enucleation rates14. Notwithstanding, macrophages may further enhance erythropoietic culture sys-
tems, as co-culture of human erythroblasts with macrophages has been shown to increase expansion rates by 
a similar magnitude to that in our present study. However, direct contact of erythroid cells with macrophages 
was required to achieve the effect3, which is undesirable when considering development for therapeutics due to 
potential contamination of the product with nucleated cells, and also the requirement for immune compatibil-
ity between macrophage and erythroid cells. In contrast our study shows not only OP9 co-culture, but also the 
application of just factors secreted by OP9 cells delay differentiation and facilitate prolonged expansion of earlier 
erythroid cell populations, importantly with no downstream block to terminal differentiation or enucleation. It is 
therefore likely that the active factors secreted by OP9 cells are distinct to those expressed by macrophages, and 
present a potentially novel way to increase erythroid cell numbers without the need for genetic manipulation or 
co-culture.
Currently, with the culture system used in our study >105 fold expansion of erythroid cells can be achieved 
in larger scale cultures18. As approximately 106 adult stem cells are isolated from an apheresis cone, this gives 
a yield of around 1011 erythroid cells from a single donor. By extrapolation, OP9-conditioned media would 
increase this yield to around 3.5 × 1011. Enucleation rates in vitro vary between 60–95%14,18 for cells from differ-
ent donors, which therefore gives a final potential yield of 2–3 × 1011 reticulocytes per culture. 1 unit of blood 
Accession Description
Unique 
Peptides Peptides
Primary 
OP9/Ctrl
Secondary 
OP9/Ctrl
Tertiary 
OP9/Ctrl
Q3TXQ4 Epididymal secretory protein E1 GN = Npc2 2 2 39.939 60.295 44.861
Q62356 Follistatin-related protein 1 GN = Fstl1 2 2 21.167 19.100 9.835
P11859 Angiotensinogen GN = Agt 5 5 9.024 20.481 9.918
Q5NCU4 SPARC GN = Sparc 11 11 6.504 12.783 7.595
Q3TP88 Collagen Type I Alpha 2 Chain GN = Col1a2 2 2 5.488 6.549 3.497
Q9QUN9 Dickkopf-related protein 3 GN = Dkk3 4 4 4.486 9.849 5.371
Q02819 Nucleobindin-1 GN = Nucb1 9 9 4.225 17.923 5.085
A0A0A6YWC8 Vimentin GN = Vim 3 3 4.065 6.724 2.217
P10605 Cathepsin B GN = Ctsb 9 9 3.667 7.885 5.122
P61982 14–3–3 protein gamma GN = Ywhag 3 5 3.372 3.440 5.582
Q9WUU7 Cathepsin Z GN = Ctsz 5 5 3.030 8.107 2.966
Q60994 Adiponectin GN = Adipoq 5 5 2.756 16.040 3.943
P11087 Collagen alpha-1(I) chain GN = Col1a1 4 4 2.679 3.763 2.071
Q8K173 Col3a1 protein GN = Col3a1 2 2 2.660 3.384 2.419
P03953 Complement factor D GN = Cfd 3 3 2.481 12.126 7.427
O09164 Extracellular superoxide dismutase [Cu-Zn] GN = Sod3 2 2 2.340 6.509 5.747
H3BLB7 Insulin-like growth factor-binding protein 4 GN = Igfbp4 2 2 2.102 12.270 3.305
P16015 Carbonic anhydrase 3 GN = Ca3 2 2 2.058 6.284 3.168
Table 3. Proteins consistently presented at a higher level across OP9-conditioned primary, secondary and 
tertiary media compared to respective control media. Culture media were serum depleted, fractionated and 
proteins subjected to trypsin digest, with resultant peptides labelled with TMTs for nanoLC-MS/MS based 
quantitation. Values show the ratio of protein levels between OP9-conditioned media and control media. 
Proteins were quantified from at least two unique peptides. Peptides and unique peptides; the total number of 
peptide sequences and number of unique peptides identified for that protein. Proteome Discoverer software 
v1.4 was used for analysis.
www.nature.com/scientificreports/
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contains around 2 × 1012 RBCs. However, the age of the population is asynchronous with a proportion of cells 
immediately removed from circulation following transfusion as are at end of lifespan. In contrast all cells from in 
vitro cultures are nascent, and therefore closely synchronous in age, with the number of cells required for trans-
fusion anticipated to be less than from donor blood. Thus the number of cells achieved from in vitro cultures is 
now approaching that required for a therapeutic product. Notwithstanding, further improvement is still required 
including development of custom filters as presently a proportion of reticulocytes are lost during this final pro-
cess, and transfer of the culture system to GMP conditions.
As a preliminary approach to identify the factors responsible for the delayed differentiation in our study, we 
analysed the secretome of the OP9 cells. Of the 18 candidate proteins identified, a role in promoting erythroid cell 
proliferation has previously been reported for angiotensinogen19, in promoting HSC proliferation for NPC220, 
14–3–3 gamma21 and adiponectin22, and in promoting proliferation of other cells types for follistatin-related 
protein 123, DKK24, secreted vimentin25, cathepsin B26 and extracellular superoxide dismutase27. Further studies 
are now underway to generate recombinant protein for each of the identified proteins to investigate their effect on 
erythroid cell expansion, both singularly and in various combinations to determine whether an individual factor 
or synergy between several factors is required.
Materials and Methods
Isolation of adult CD34+ cells. Leucocyte reduction system (LRS) cones were obtained from healthy 
donors with written informed consent for research use in accordance with the Declaration of Helsinki and 
approved by Siriraj Institutional Review Board (COA no. Si019/2016). Three LRS cones from 3 donors were used 
for each part of experiment (n = 3). The CD34+ cells were isolated from the peripheral blood mononuclear cell 
fraction using a MiniMacs direct CD34+ progenitor cell isolation kit following the manufacturer’s instructions.
Erythroid differentiation of CD34+ cells. The CD34+ cells were cultured using the 3-stage erythroid 
culture system. During the first 8 days the cells were maintained in Basic medium which was Iscove’s medium 
(Biochrom) containing 3% (v/v) human AB serum (Sigma-Aldrich), 10% fetal calf serum (Hyclone, Fisher 
Scientific, Ltd), 10 μg/ml insulin (Sigma-Aldrich), 3 U/ml heparin (Sigma-Aldrich), 3 U/ml EPO (Roche), 200 μg/
ml transferrin (R&D Systems) and 1 U/ml penicillin/streptomycin (Sigma-Aldrich) supplemented with 10 ng/ml 
SCF (R&D Systems) and 1 ng/ml IL-3 (R&D Systems) (primary medium). IL-3 and SCF were withdrawn from 
the medium on day 8 (secondary medium) and 11 (tertiary medium), respectively. In addition, extra transferrin 
was added to the medium to the final concentration of 500 μg/ml from day 11 onward. The cells were counted and 
medium was added every other day. The cultured cells were maintained at 37 °C, 5% CO2 throughout the culture 
period. At indicated time points, aliquots of cells were collected for morphological analysis using cytospin and 
Leishman staining. Two sample equal variance t-test was carried out to determine the statistic significances of cell 
numbers and cell types.
Culture system for OP9 cells. OP9 mouse stromal cells were maintained in the OP9 growth medium, 
consisting of αMEM culture medium (Invitrogen) containing 100 μM 1-Thioglycerol (MTG) (Sigma-Aldrich), 
100 U/ml penicillin/streptomycin and 20% (v/v) FCS. OP9 cells were separated and expanded every 4 days, when 
the cells were confluent, by trypsinisation. The harvested cells were seeded onto a 10-cm dish coated with 0.1% 
bovine gelatin solution (Sigma-Aldrich).
Tandem Mass Tag labeling, preparation of samples for Mass Spectrometry, database search 
parameters and acceptance criteria for identifications. As all media contain both bovine and human 
serum, the high level of proteins from which could mask identification of proteins secreted by the OP9 cells, the 
media were serum depleted using a Pierce albumin depletion kit for bovine proteins followed by Pierce top 12 
abundant protein depletion spin columns for human proteins. Remaining proteins were subject to trypsin cleav-
age, and the resultant peptides labeled with isobaric Tandem Mass Tags for comparative quantitation, and ana-
lysed by nanoLC-MS/MS, as previously described11. Following analysis against the UniProt Mouse database (see 
main text) we next searched the raw data files against the UniProt Human (134169 entries) and Bovine (31855 
entries) databases (Suppl Table 4). For analysis only quantifications obtained from two or more unique peptides 
per protein were considered, with a comparative threshold of 216.
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